| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 99, 670-673, Copyright © 1991 by American College of Chest Physicians
ARTICLES |
H Miyatake, F Taki, H Taniguchi, R Suzuki, K Takagi and T Satake
Second Department of Internal Medicine and Clinical Laboratory, Nagoya University School of Medicine, Japan.
It has been demonstrated that bronchial hyperresponsiveness is a characteristic feature of bronchial asthma, and airway inflammation plays an important role in bronchial hyperresponsiveness. Erythromycin is an antibiotic extensively used worldwide which is also reported to have anti-inflammatory action. This study was designed to clarify whether erythromycin could favorably alter bronchial responsiveness in patients with bronchial asthma. To estimate bronchial responsiveness, histamine challenge was performed in 23 patients with bronchial asthma (atopic type, 11; nonatopic type, 12). All patients were treated for ten weeks with erythromycin, 200 mg three times daily, orally. After ten weeks' treatment, PC20, an index of bronchial sensitivity, was increased significantly. There was no difference between atopic and nonatopic patients in the improvement of PC20. It was concluded that erythromycin reduces the severity of bronchial responsiveness in patients with bronchial asthma.
This article has been cited by other articles:
|
|
 |
|
  S. Ragab, G. K. Scadding, V. J. Lund, and H. Saleh Treatment of chronic rhinosinusitis and its effects on asthma Eur. Respir. J., July 1, 2006; 28(1): 68 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. F. Little Treating Acute Asthma with Antibiotics -- Not Quite Yet N. Engl. J. Med., April 13, 2006; 354(15): 1632 - 1634. [Full Text] [PDF]
|
|
|
|
 |
|
 S C Bell, S L Senini, and J G McCormack Macrolides in cystic fibrosis Chronic Respiratory Disease, April 1, 2005; 2(2): 85 - 98. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Basyigit, F. Yildiz, S. K. Ozkara, E. Yildirim, H. Boyaci, and A. Ilgazli The Effect of Clarithromycin on Inflammatory Markers in Chronic Obstructive Pulmonary Disease: Preliminary Data Ann. Pharmacother., September 1, 2004; 38(9): 1400 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kostadima, S. Tsiodras, E.I. Alexopoulos, A.G. Kaditis, I. Mavrou, N. Georgatou, and A. Papamichalopoulos Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma Eur. Respir. J., May 1, 2004; 23(5): 714 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Gotfried Macrolides for the Treatment of Chronic Sinusitis, Asthma, and COPD Chest, February 1, 2004; 125(2_suppl): 52S - 61S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Abeyama, K.-i. Kawahara, S. Iino, T. Hamada, S.-i. Arimura, K. Matsushita, T. Nakajima, and I. Maruyama Antibiotic cyclic AMP signaling by "primed" leukocytes confers anti-inflammatory cytoprotection J. Leukoc. Biol., November 1, 2003; 74(5): 908 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shimizu, S. Shimizu, R. Hattori, E. C. Gabazza, and Y. Majima In Vivo and In Vitro Effects of Macrolide Antibiotics on Mucus Secretion in Airway Epithelial Cells Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 581 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Hardy, A. M. Rios, S. Chavez-Bueno, H. S. Jafri, J. Hatfield, B. B. Rogers, G. H. McCracken, and O. Ramilo Antimicrobial and Immunologic Activities of Clarithromycin in a Murine Model of Mycoplasma pneumoniae-Induced Pneumonia Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1614 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Garey, A. Alwani, L. H. Danziger, and I. Rubinstein Tissue Reparative Effects of Macrolide Antibiotics in Chronic Inflammatory Sinopulmonary Diseases Chest, January 1, 2003; 123(1): 261 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kraft, G. H. Cassell, J. Pak, and R. J. Martin Mycoplasma pneumoniae and Chlamydia pneumoniae in Asthma* : Effect of Clarithromycin Chest, June 1, 2002; 121(6): 1782 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kikuchi, K. Hagiwara, Y. Honda, K. Gomi, T. Kobayashi, H. Takahashi, Y. Tokue, A. Watanabe, and T. Nukiwa Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-{kappa}B transcription factors J. Antimicrob. Chemother., May 1, 2002; 49(5): 745 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sato, D. K. Nelson, S. Koyama, J. C. Hoyt, and R. A. Robbins Erythromycin Modulates Eosinophil Chemotactic Cytokine Production by Human Lung Fibroblasts in Vitro Antimicrob. Agents Chemother., February 1, 2001; 45(2): 401 - 406. [Abstract] [Full Text]
|
|
|
|
|
|
K. W. Garey, I. Rubinstein, M. H. Gotfried, I. J. Khan, S. Varma, and L. H. Danziger Long-term Clarithromycin Decreases Prednisone Requirements in Elderly Patients With Prednisone-Dependent Asthma Chest, December 1, 2000; 118(6): 1826 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Abe, H. Nakamura, S. Inoue, H. Takeda, H. Saito, S. Kato, N. Mukaida, K. Matsushima, and H. Tomoike Interleukin-8 Gene Repression by Clarithromycin Is Mediated by the Activator Protein-1 Binding Site in Human Bronchial Epithelial Cells Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 51 - 60. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. C. Y. Woo, H.-W. Tsoi, L.-P. Wong, H. C. H. Leung, and K.-Y. Yuen Antibiotics Modulate Vaccine-Induced Humoral Immune Response Clin. Vaccine Immunol., November 1, 1999; 6(6): 832 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tamaoki, M. Kondo, K. Kohri, K. Aoshiba, E. Tagaya, and A. Nagai Macrolide Antibiotics Protect Against Immune Complex-Induced Lung Injury in Rats: Role of Nitric Oxide from Alveolar Macrophages J. Immunol., September 1, 1999; 163(5): 2909 - 2915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Cook Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma J. Antimicrob. Chemother., August 1, 1999; 44(2): 145 - 148. [Full Text] [PDF]
|
|
|
|
|
|
T. Kohyama, H. Takizawa, S. Kawasaki, N. Akiyama, M. Sato, and K. Ito Fourteen-Member Macrolides Inhibit Interleukin-8 Release by Human Eosinophils from Atopic Donors Antimicrob. Agents Chemother., April 1, 1999; 43(4): 907 - 911. [Abstract] [Full Text]
|
|
|
|
|
|
K. Sassa, Y. Mizushima, T. Fujishita, R. Oosaki, and M. Kobayashi Therapeutic Effect of Clarithromycin on a Transplanted Tumor in Rats Antimicrob. Agents Chemother., January 1, 1999; 43(1): 67 - 72. [Abstract] [Full Text]
|
|
|
|
|
|
H. TAKIZAWA, M. DESAKI, T. OHTOSHI, S. KAWASAKI, T. KOHYAMA, M. SATO, M. TANAKA, T. KASAMA, K. KOBAYASHI, J. NAKAJIMA, et al. Erythromycin Modulates IL-8 Expression in Normal and Inflamed Human Bronchial Epithelial Cells Am. J. Respir. Crit. Care Med., July 1, 1997; 156(1): 266 - 271. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
